首页> 外文期刊>The breast journal >Is there a Reliable Method to Assess the Complete Pathologic Response on the Tumor after Neo-adjuvant Chemotherapy in Inflammatory Breast Cancer toward Recommendations for the Pathologic Process?Experience in 56 Patients Treated in a Single Institution
【24h】

Is there a Reliable Method to Assess the Complete Pathologic Response on the Tumor after Neo-adjuvant Chemotherapy in Inflammatory Breast Cancer toward Recommendations for the Pathologic Process?Experience in 56 Patients Treated in a Single Institution

机译:有没有一种可靠的方法可以评估炎症性乳腺癌新辅助化疗后对肿瘤的完整病理反应,以针对病理过程的建议?单一机构治疗56例患者的经验

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study was to compare the complete pathologic response (CPR) rate in 56 nonmetastatic inflammatory breast cancer patients according to the classification used and to look for a correlation between the CPR and overall survival. Initial biopsies and mastectomy specimens were reviewed by the same pathologist. The clinical response rate was 75%. A CPR was observed in 11 cases according to Sataloff, three according to Chevallier and five according to the NSABP. There was no correlation between the clinical and pathologic responses and none of them was predictive of relapse free survival or overall survival. We propose a standardization of the pathologic process of the mastectomy specimens so that a CPR has a clear definition across the institutions, with a good reproducibility whatever the classification used.
机译:这项研究的目的是根据所用分类比较56名非转移性炎性乳腺癌患者的完整病理反应(CPR)率,并寻找CPR与总体生存率之间的相关性。最初的活检和乳房切除术标本由同一病理学家进行了检查。临床反应率为75%。 Sataloff指出有11例患者发生了心肺复苏,Chevallier指出有3例,NSABP指出有5例。临床和病理反应之间没有相关性,而且都不能预测无复发生存或总体生存。我们建议对乳房切除术标本的病理过程进行标准化处理,以便使CPR在各个机构中都有明确的定义,并且无论使用哪种分类,都具有良好的可重复性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号